# EVEROLIMUS
> **ANDA218863** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2025-01-10
## Drug
- **FDA Application Number:** ANDA218863
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EVEROLIMUS
- **Generic name:** EVEROLIMUS
- **Active ingredients:** EVEROLIMUS
- **Dosage form:** TABLET, FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AMNEAL
- **Manufacturer:** Amneal Pharmaceuticals NY LLC
- **First approval:** 2025-01-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218863)
---
*AI Analytics · CC0 1.0*